Bone Substitute Options for Spine Fusion in Patients With Spine Trauma-Part II: The Role of RhBMP

Overview

Journal Korean J Neurotrauma

Date 2024 Apr 5

PMID 38576507

Authors

Min Cheol Seok

Hae-Won Koo

Je Hoon Jeong

Myeong Jin Ko

Byung-Jou Lee

Affiliations

Soon will be listed here.

Abstract

In Part II, we focus on an important aspect of spine fusion in patients with spine trauma: the pivotal role of recombinant human bone morphogenetic protein-2 (rhBMP-2). Despite the influx of diverse techniques facilitated by technological advancements in spinal surgery, spinal fusion surgery remains widely used globally. The persistent challenge of spinal pseudarthrosis has driven extensive efforts to achieve clinically favorable fusion outcomes, with particular emphasis on the evolution of bone graft substitutes. Part II of this review aims to build upon the foundation laid out in Part I by providing a comprehensive summary of commonly utilized bone graft substitutes for spinal fusion in patients with spinal trauma. Additionally, it will delve into the latest advancements and insights regarding the application of rhBMP-2, offering an updated perspective on its role in enhancing the success of spinal fusion procedures.

References

Seo D, Kim M, Roh S, Jeon S . Morphological analysis of interbody fusion following posterior lumbar interbody fusion with cages using computed tomography. Medicine (Baltimore). 2017; 96(34):e7816. PMC: 5572007. DOI: 10.1097/MD.0000000000007816. View

Boden S . Overview of the biology of lumbar spine fusion and principles for selecting a bone graft substitute. Spine (Phila Pa 1976). 2002; 27(16 Suppl 1):S26-31. DOI: 10.1097/00007632-200208151-00007. View

Boden S, Zdeblick T, Sandhu H, Heim S . The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: a preliminary report. Spine (Phila Pa 1976). 2000; 25(3):376-81. DOI: 10.1097/00007632-200002010-00020. View

Sandhu H, Kanim L, Kabo J, Toth J, Zeegen E, Liu D . Effective doses of recombinant human bone morphogenetic protein-2 in experimental spinal fusion. Spine (Phila Pa 1976). 1996; 21(18):2115-22. DOI: 10.1097/00007632-199609150-00012. View

Wozney J, Rosen V, Celeste A, Mitsock L, Whitters M, Kriz R . Novel regulators of bone formation: molecular clones and activities. Science. 1988; 242(4885):1528-34. DOI: 10.1126/science.3201241. View

Valentin-Opran A, Wozney J, Csimma C, Lilly L, Riedel G . Clinical evaluation of recombinant human bone morphogenetic protein-2. Clin Orthop Relat Res. 2002; (395):110-20. DOI: 10.1097/00003086-200202000-00011. View

Kessler E, Takahara K, Biniaminov L, Brusel M, Greenspan D . Bone morphogenetic protein-1: the type I procollagen C-proteinase. Science. 1996; 271(5247):360-2. DOI: 10.1126/science.271.5247.360. View

Kaiser M, Groff M, Watters 3rd W, Ghogawala Z, Mummaneni P, Dailey A . Guideline update for the performance of fusion procedures for degenerative disease of the lumbar spine. Part 16: bone graft extenders and substitutes as an adjunct for lumbar fusion. J Neurosurg Spine. 2014; 21(1):106-32. DOI: 10.3171/2014.4.SPINE14325. View

Boden S, Kang J, Sandhu H, Heller J . Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies. Spine (Phila Pa 1976). 2002; 27(23):2662-73. DOI: 10.1097/00007632-200212010-00005. View

10.

Boden S, Martin Jr G, Morone M, Ugbo J, Moskovitz P . Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2/hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate. Spine (Phila Pa 1976). 1999; 24(12):1179-85. DOI: 10.1097/00007632-199906150-00002. View

11.

Balemans W, Van Hul W . Extracellular regulation of BMP signaling in vertebrates: a cocktail of modulators. Dev Biol. 2002; 250(2):231-50. View

12.

Carragee E, Bono C, Scuderi G . Pseudomorbidity in iliac crest bone graft harvesting: the rise of rhBMP-2 in short-segment posterior lumbar fusion. Spine J. 2009; 9(11):873-9. DOI: 10.1016/j.spinee.2009.09.001. View

13.

Katagiri T, Watabe T . Bone Morphogenetic Proteins. Cold Spring Harb Perspect Biol. 2016; 8(6). PMC: 4888821. DOI: 10.1101/cshperspect.a021899. View

14.

Ebara S, Nakayama K . Mechanism for the action of bone morphogenetic proteins and regulation of their activity. Spine (Phila Pa 1976). 2002; 27(16 Suppl 1):S10-5. DOI: 10.1097/00007632-200208151-00004. View

15.

Asai-Coakwell M, French C, Berry K, Ye M, Koss R, Somerville M . GDF6, a novel locus for a spectrum of ocular developmental anomalies. Am J Hum Genet. 2007; 80(2):306-15. PMC: 1785352. DOI: 10.1086/511280. View

16.

Luu H, Song W, Luo X, Manning D, Luo J, Deng Z . Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells. J Orthop Res. 2007; 25(5):665-77. DOI: 10.1002/jor.20359. View

17.

Shah P, Keppler L, Rutkowski J . Bone morphogenic protein: an elixir for bone grafting--a review. J Oral Implantol. 2011; 38(6):767-78. DOI: 10.1563/AAID-JOI-D-10-00196. View

18.

Sidhu K, Prochnow T, Schmitt P, Fischgrund J, Weisbrode S, Herkowitz H . Anterior cervical interbody fusion with rhBMP-2 and tantalum in a goat model. Spine J. 2003; 1(5):331-40. DOI: 10.1016/s1529-9430(01)00113-9. View

19.

Otsuka F, Yao Z, Lee T, Yamamoto S, Erickson G, Shimasaki S . Bone morphogenetic protein-15. Identification of target cells and biological functions. J Biol Chem. 2000; 275(50):39523-8. DOI: 10.1074/jbc.M007428200. View

20.

Abe E, Yamamoto M, Taguchi Y, Lecka-Czernik B, OBrien C, Economides A . Essential requirement of BMPs-2/4 for both osteoblast and osteoclast formation in murine bone marrow cultures from adult mice: antagonism by noggin. J Bone Miner Res. 2000; 15(4):663-73. DOI: 10.1359/jbmr.2000.15.4.663. View